Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus (RIFA-SNAP)

NCT07253688 is registered in ClinicalTrials.gov with Todd C. Lee MD MPH FIDSA as lead sponsor.

NCT NCT07253688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07253688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus (RIFA-SNAP)
Lead sponsor
Todd C. Lee MD MPH FIDSA
Phase
Phase 3
Overall status
Terminated
Start date
November 10, 2025
Completion date
September 14, 2026
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prosthetic valve endocarditis, staphylococcus aureus endocarditis